Targeted deep sequencing of a panel of 8 genes frequently mutated in BC (AKT1, CDH1, ERBB2, NOTCH1, PIK3CA, PTEN, RB1, and TP53) was successfully performed on 126 cases for which more than 250 ng of tumor genomic DNA was available. This evidence concerns the gene TP53 and breast cancer.